Active ingredientPixantrone DimaleateCat. No. P-P144-001CAS 144675-97-8Family · Pharmaceutical analytical standards
Pixantrone
An anticancer drug analogous to mitoxantrone, which intercalates into DNA and poisons topoisomerase II: it was developed to reduce treatment-related heart damage. In 2012 it received conditional marketing authorisation in the European Union for some aggressive B-cell non-Hodgkin lymphomas. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It was chosen as the most promising compound in a search for 'heteroanalogues' of anthracenediones, in which a nitrogen atom enters the ring system; in pure form it is a blue solid.
Go to the active ingredient →Active ingredientPixantrone DimaleateCat. No. P-P144-001CAS 144675-97-8
Isotopically labelledPixantrone-d8 DimaleateCat. No. P-P144-003CAS 2012601-55-5
Impurity6-fluoro PixantroneCat. No. P-P144-004
Impurity6-Pixantrone Mono Maleinamide adductCat. No. P-P144-005
Impurity9-fluoro PixantroneCat. No. P-P144-006
Impurity9-Pixantrone Mono Maleinamide adductCat. No. P-P144-007
ImpurityPixantrone Impurity 1Cat. No. P-P144-008
ImpurityPixantrone Impurity 2Cat. No. P-P144-009
ImpurityPixantrone Impurity 3Cat. No. P-P144-010
ImpurityPixantrone Impurity BCat. No. P-P144-011CAS 144510-94-1
ImpurityPixantrone Impurity DCat. No. P-P144-012
ImpurityPixantrone-N7-desethanamineCat. No. P-P144-013No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.